Hsbc Holdings PLC Takes Position in Revvity Inc. $RVTY

Hsbc Holdings PLC bought a new position in shares of Revvity Inc. (NYSE:RVTY) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 177,678 shares of the company’s stock, valued at approximately $19,762,000.

A number of other institutional investors have also made changes to their positions in RVTY. Primecap Management Co. CA purchased a new stake in Revvity in the second quarter valued at approximately $94,921,000. Canada Pension Plan Investment Board purchased a new position in Revvity during the 2nd quarter valued at about $656,000. Legal & General Group Plc acquired a new position in Revvity in the 2nd quarter valued at about $31,388,000. The Manufacturers Life Insurance Company purchased a new stake in Revvity during the second quarter worth about $41,048,000. Finally, Sone Capital Management LLC acquired a new stake in shares of Revvity during the second quarter worth about $12,212,000. 86.65% of the stock is currently owned by institutional investors and hedge funds.

Key Stories Impacting Revvity

Here are the key news stories impacting Revvity this week:

• Positive Sentiment: Zacks Research raised its FY2026 EPS forecast to $5.38 from $5.25, slightly above the $5.36 consensus estimate. The firm also increased its FY2027 forecast to $5.86 from $5.77, while lifting Q1 2027 EPS to $1.17 and Q4 2027 EPS to $1.77. These revisions suggest improving expectations for longer-term earnings growth. Revvity analyst estimates
• Neutral Sentiment: Zacks maintained a Hold rating, limiting the bullish impact of the higher estimates. Revvity’s latest reported quarter also exceeded expectations, with EPS of $1.41 versus the $1.21 consensus and revenue of $729.7 million versus $703.0 million, although revenue declined 1.3% year over year.
• Neutral Sentiment: An analysis highlighted that Revvity faces a new test after its strong advance. With the shares near their annual high, investors may focus on whether future operating improvement can justify the recent valuation and momentum. Revvity faces a new test after its strong run
• Negative Sentiment: Zacks lowered several quarterly forecasts, including Q3 2026 EPS to $1.27 from $1.30, Q4 2026 EPS to $1.64 from $1.67, Q3 2027 EPS to $1.42 from $1.44, and Q2 2028 EPS to $1.62 from $1.64. The cuts indicate some uncertainty around near-term earnings momentum.

Analyst Ratings Changes

Several brokerages recently weighed in on RVTY. Evercore reaffirmed an “outperform” rating on shares of Revvity in a research note on Wednesday, August 5th. Zacks Research upgraded Revvity from a “strong sell” rating to a “hold” rating in a research note on Tuesday, August 4th. Weiss Ratings raised Revvity from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, July 30th. Sanford C. Bernstein assumed coverage on Revvity in a report on Friday, June 26th. They set a “market perform” rating and a $115.00 price target on the stock. Finally, TD Cowen reiterated a “buy” rating on shares of Revvity in a research note on Wednesday, July 15th. Three analysts have rated the stock with a Buy rating and twelve have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $108.36.

Revvity Price Performance

Shares of RVTY opened at $129.30 on Friday. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.80 and a quick ratio of 1.50. Revvity Inc. has a 1-year low of $81.22 and a 1-year high of $129.80. The stock has a market cap of $14.43 billion, a PE ratio of 61.57, a price-to-earnings-growth ratio of 2.30 and a beta of 1.07. The firm has a fifty day moving average price of $113.52 and a 200 day moving average price of $101.02.

Revvity (NYSE:RVTY) last posted its earnings results on Tuesday, August 4th. The company reported $1.41 EPS for the quarter, topping analysts’ consensus estimates of $1.21 by $0.20. The business had revenue of $729.69 million for the quarter, compared to analysts’ expectations of $702.96 million. Revvity had a return on equity of 8.34% and a net margin of 8.16%.The business’s revenue was down 1.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.18 earnings per share. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. As a group, sell-side analysts anticipate that Revvity Inc. will post 5.36 EPS for the current year.

Revvity Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Friday, October 23rd will be issued a $0.07 dividend. This represents a $0.28 annualized dividend and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, October 23rd. Revvity’s dividend payout ratio is presently 13.33%.

Revvity Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.